Reversible cerebral Vasoconstriction syndrome intERnational CollaborativE (REVERCE) network: Study protocol and rationale of a multicentre research collaboration.
Kristin Sophie LangeSo Youn ChoiYu-Hsiang LingShih-Pin ChenJérôme MawetClaire DuflosMi Ji LeeAnne DucrosShuu-Jiun WangAlessandro PezziniPublished in: European stroke journal (2023)
Ethical approval for the REVERCE study will be obtained from national or local institutional review boards in the participating centres. When needed, a standardised data transfer agreement will be provided for participating centres. We plan dissemination of our results in peer-reviewed international scientific journals and through conference presentations. We expect that the results of this unique study will lead to better understanding of clinical and epidemiological characteristics of RCVS patients.
Keyphrases
- study protocol
- end stage renal disease
- clinical trial
- randomized controlled trial
- newly diagnosed
- quality improvement
- ejection fraction
- chronic kidney disease
- machine learning
- systematic review
- electronic health record
- peritoneal dialysis
- prognostic factors
- open label
- blood brain barrier
- cross sectional
- deep learning
- artificial intelligence